Heart problems caused by experimental Covid gene therapy drugs are not limited to inflammation of the heart muscle. A recent study describes the case of a 59-year-old patient who suffered so-called Takotsubo cardiomyopathy with severe enlargement of the heart following a booster vaccination. They did not have any risk factors for heart disease.
The case study by Reza et al, published in Curious on 10 August, begins with the well-known assurance that Covid vaccines are in fact quite safe and effective anyway, but then notes that there are already a number of cardiovascular side effects – namely myocarditis, pericarditis, myopericarditis, myocardial infarction, pulmonary embolism, thrombotic thrombocytopenia and pulmonary hemorrhage – were known and new ones continue to be known. One of them: Takotsubo cardiomyopathy (TCM). Described a case of a 59-year-old patient who presented to the emergency room with shortness of breath for six hours and also complained of recurrent chest pain over the previous two days. Three days ago, he had received the booster of the Moderna Covid vaccine. He had a history of hypothyroidism, elevated blood lipids and celiac disease, but had no heart problems prior to vaccination.
Tested negative for Covid-19. ECG and transthoracic echocardiography showed obvious abnormalities in heart function and doctors also found pulmonary edema in X-rays. The patient was suffering from frequent tachycardia and fluctuations in blood pressure. In the process she went into shock. pulmonary embolism and thrombotic or obstructive lesions in the coronary vessels can be ruled out, However, an MRI revealed a clearly ballooning heart but no myocarditis. Based on this and on the basis of previous corona vaccinations, doctors diagnosed TCM – no other cause could be found for serious heart problems.
The patient was treated with systemic hydrocortisone, systemic furosemide, heparin, and norepinephrine; Fortunately, his condition improved over the next few days.
TCM is actually very rare, found in only one percent of all patients suspected of acute coronary artery disease. The exact reasons are unknown; This form of cardiomyopathy is often associated with emotional stress and trauma, which is why the disease is also known as stress cardiomyopathy or “broken heart syndrome”. Physical stress, hormonal imbalance and certain medications are also associated with the condition. The 59-year-old man had no identifiable trigger for TCM – other than the immediately preceding vaccination. The authors point out that a study was previously published that examined multiple cases of TCM as a result of Covid vaccination. This phenomenon is rare, but apparently not an isolated case.
Multiple theories on pathophysiology
Exactly how vaccination leads to Takotsubo cardiomyopathy is unclear. The authors offer several theories in this regard:
The pathophysiology of TCM induced by the COVID-19 vaccine is unknown; However, several theories have been proposed. The COVID-19 vaccines elicit an immune response aimed at producing protective antibodies against the SARS-CoV-2 virus. However, in some individuals, this immune response may result in exaggerated swelling cascade Endothelial dysfunction causes microvascular dysfunction and myocardial damage. release of pro-inflammatory cytokines such as interleukin-6 (IL-6) may contribute to the pathophysiology of TCM (13). The autonomic nervous system plays an important role in regulating heart function. Excessive activation of the sympathetic nervous system due to excessive release of catecholamines and decreased parasympathetic tone have been implicated in the pathogenesis of TCM. the one with Stress related to COVID-19 vaccination may potentially result in disturbances in the autonomic nervous system and contribute to the development of cardiac dysfunction (14). Endothelial dysfunction and impaired coronary microvascular function have been observed in TCM. COVID-19 vaccines can induce transient endothelial dysfunction and microvascular abnormalities, Which impairs coronary blood flow and subsequently causes myocardial dysfunction (15).
What: Reza et al. 2023
Overall, the study suggests that post-Covid heart problems are not limited to myocarditis and pericarditis, and physicians need to be more vigilant in providing the right treatment to their patients (and thus saving their lives).
The claim that “the benefits outweigh the risks”, which the authors of the study ultimately put forward, has now turned into a cliché apparently intended to enable the study to be published – even if it contradicts the facts. Refutes Because no concrete benefit of gene therapy has yet been proven in high-quality and meaningful studies. Against this background, every side effect is simply one too many.
